Candida Rugosa
Also known as: Candida rugosa lipase, CRL
Overview
Candida rugosa lipase (CRL) is an enzyme extracted from the yeast species Candida rugosa, classified as a lipase, which plays a crucial role in lipid metabolism by catalyzing the hydrolysis of fats into free fatty acids and glycerol. This enzyme is noted for its stability across various pH levels and temperatures, enhancing its efficacy in diverse gastrointestinal environments. Primarily, CRL is utilized as a dietary supplement aimed at improving fat digestion and enriching the gut microbiome. Research surrounding CRL is at an emerging stage, with animal studies indicating its potential in fostering a beneficial gut microbiome. However, human studies remain limited, making comprehensive assessments difficult but suggesting promising implications in gut health maintenance.
Benefits
Research suggests that CRL supplementation notably alters the gut microbiome, especially in mice, promoting the growth of beneficial bacterial species like Verrucomicrobia and Akkermansia muciniphila, linked to improved gut health. The enzyme maintains its activity within the intestinal tract, enhancing free fatty acid concentrations believed to support energy metabolism. While specific effect sizes or confidence intervals are not reported, statistically significant changes (p < 0.05) indicate clinical relevance. Additionally, CRL does not compromise gut barrier integrity, suggesting its safe application. Although most evidence stems from preclinical studies, the findings imply potential benefits for maintaining gut microbiome health and aiding in fat digestion in humans.
How it works
CRL operates by hydrolyzing triglycerides into free fatty acids and glycerol, which are essential substrates for beneficial gut bacteria, thus modulating the gut microbiome. This enzymatic process primarily occurs within the gastrointestinal system, enhancing the composition of bacterial species favorably. Importantly, CRL's biological activity is preserved in the intestinal tract, reflecting its effective absorption and bioavailability beyond the stomach.
Side effects
The safety profile of CRL appears favorable, with animal studies indicating no significant adverse effects or harm to gut barrier integrity. There are no documented reports of common side effects exceeding 5%, nor are any uncommon (1-5%) or rare side effects (<1%) noted in the literature reviewed. However, caution is encouraged due to the absence of human trials confirming long-term safety. Potential drug interactions are not sufficiently documented, so individuals should consult healthcare professionals prior to beginning supplementation. Furthermore, due to the limited research, CRL's safety in special populations, such as pregnant women, children, or those with particular health conditions, remains unexplored.
Dosage
Current evidence does not establish a minimum effective dose for human use; however, animal studies suggest doses ensuring enzyme activity in the intestinal tract. Optimal dosage ranges remain undefined and would require further clinical trials to elucidate. No maximum safe dose has been identified, as animal studies have not reported adverse effects within the tested doses. Dosage timing—ideally with meals—may optimize fat digestion. CRL can be administered in different formulations, including immobilized systems that enhance stability. Its high activity in the intestinal tract points toward effective absorption, though specific cofactor requirements are currently unknown.
FAQs
How should I take CRL?
It is advisable to take CRL with meals to enhance fat digestion.
Is CRL safe for consumption?
CRL appears to be safe based on animal studies, but human safety data is needed for confirmation.
What benefits can I expect from CRL?
Users may anticipate improved gut health and fat digestion, based on emerging research findings.
Research Sources
- https://experts.umn.edu/en/publications/candida-rugosa-lipase-alters-the-gastrointestinal-environment-in- – This animal study demonstrated that CRL influences the gastrointestinal environment in mice, promoting the growth of beneficial gut bacteria without compromising gut integrity.
- https://www.mdpi.com/2073-4344/12/8/854 – This study characterized CRL's biochemical and physical properties, illustrating its high stability under various conditions through immobilization techniques.
- https://www.mdpi.com/2073-4344/11/4/421 – This in vitro research showcased the successful codisplay of CRL with another lipase, supporting the enzyme's application in advanced biotechnological processes.
Supplements Containing Candida Rugosa

BioCore Lipo
Swanson

Maximum Strength BioCore Lipo
Swanson Ultra

Certified Men's Multivitamin
RAINBOW LIGHT®

HIGH POTENCY WOMEN'S ONE DAILY MULTIVITAMIN
Rainbow Light®
HALLELUJAH DIET® DIGESTIVE ENZYMES
Hallelujah Diet®

MassZymes
BiOptimizers

WOMEN'S MULTIVITAMIN
THE EDISON SYSTEM. everyday

IsaLean® Performance Protein
Isagenix®

Go-Digest
GOLO®

GreenSynergy Elixir
arbonne.

THER-BIOTIC® Vital-Zymes Chewable™
SFI®

DIGEST FACTOR
PUREFACTOR FORMULATIONS™
Recommended Articles

Rhodiola Supplements: Effective Ingredients & Levels
Rhodiola rosea supplements should be standardized to 3% rosavins for stress management efficacy.

Melatonin & Chronic Insomnia: Effectiveness & Dosage
Melatonin is generally effective for chronic insomnia, with minimal side effects and varied dosages.

Berberine vs Metformin: Weight Loss Showdown 2025
Berberine and metformin both show promising weight loss effects by activating AMPK, with berberine possibly having a slight edge in certain populations.

CBD for Chronic Pain: 2025 Clinical Trial Insights
CBD shows promising results in chronic pain management, with clinical trials up to 2025 highlighting its safety and efficacy.